Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jiaqi Di, Xuanlin Li, Jingjing Yang, Luguang Li & Xueqing Yu. (2022) Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study. Risk Management and Healthcare Policy 15, pages 1189-1201.
Read now
Read now
Articles from other publishers (20)
Karina Smidt Simon, Luísa Coutinho Coelho, Paulo Henrique de Holanda VelosoJr.Jr., Cesar Augusto Melo-Silva, José Athayde Vasconcelos Morais, João Paulo Figueiró Longo, Florencio Figueiredo, Leonora Viana, Ildinete Silva Pereira, Veronica Moreira Amado, Marcia Renata Mortari & Anamelia Lorenzetti Bocca. (2023) Innovative Pre-Clinical Data Using Peptides to Intervene in the Evolution of Pulmonary Fibrosis. International Journal of Molecular Sciences 24:13, pages 11049.
Crossref
Crossref
Hamdan AL-Jahdali, Anwar Ahmed, Abdullah AL-Harbi, Ayaz Khan, Majed ALGamedi, Sami Alyami, Hajar Hayyan, Mohamed Al-Moamary & Ahmed Almuttari. (2023) The most common pulmonary diseases length of stay, and characteristics of patients admitted to pulmonary service. Annals of Thoracic Medicine 18:3, pages 124.
Crossref
Crossref
Alyson W. Wong, John Koo, Christopher J. Ryerson, Mohsen Sadatsafavi & Wenjia Chen. (2022) A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Ladan Panahi, George Udeani, Andrew Scott Tenpas, Theresa Ofili, Elizabeth Marie Aguilar, Sarah Burchard, Alexandra Ruth Ritenour, April Jacob Chennat, Nehal Ahmed, Chairat Atphaisit, Crystal Chi, Jesus Cruz III, Monica D. Deleon, Samantha Lee, Zack Mayo, Mackenzie Mcbeth, Mariel Morales, Jennifer N. Nwosu, Kelly Palacios, Jaycob M. Pena & Nitza Vara. 2022. Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis.
Sun-Hyung Kim, Dong-Hwa Lee, Bumhee Yang, Jun Yeun Cho, Hyeran Kang, Kang Hyeon Choe, Ki Man Lee & Yoon Mi Shin. (2022) Which factors are helpful for the early determination of treatment level in patients with interstitial lung disease in the intensive care unit to minimize the suffering in their end of life?: A retrospective study. Medicine 101:37, pages e30524.
Crossref
Crossref
Hyun J. Kim, Laurie D. Snyder, Ayodeji Adegunsoye, Megan L. Neely, Shaun Bender, Eric S. White, Craig S. Conoscenti, Mary E. Strek, Albert Baker, Scott Beegle, John A. Belperio, Rany Condos, Francis Cordova, Daniel A. Culver, Daniel Dilling, John Fitzgerald, Leann Silhan, Kevin R. Flaherty, Kevin Gibson, Mridu Gulati, Kalpalatha Guntupalli, Nishant Gupta, Amy Hajari Case, David Hotchkin, Tristan J. Huie, Robert J. Kaner, Hyun J. Kim, Lisa H. Lancaster, Mark Steele, Joseph A. Lasky, Doug Lee, Timothy Liesching, Randolph Lipchik, Jason Lobo, Tracy R. Luckhardt, Joao A. Andrade, Yolanda Mageto, Howard Huang, Prema Menon, Yolanda Mageto, Lake Morrison, Andrew Namen, Justin M. Oldham, Tessy Paul, David Zhang, Anna Podolanczuk, David Lederer, Nina M. Patel, Mary Porteous, Maryl Kreider, Rishi Raj, Paul Mohabir, Murali Ramaswamy, Tonya Russell, Paul Sachs, Zeenat Safdar, Shirin Shafazand, Marilyn Glassberg, Ather Siddiqi, Wael Asi, Barry Sigal, Mary E. Strek, Imre Noth, Sally Suliman, Jesse Roman, Jeremy Tabak, Rajat Walia & Timothy P. M. Whelan. (2021) Hospitalizations in patients with idiopathic pulmonary fibrosis. Respiratory Research 22:1.
Crossref
Crossref
Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah & Andrew H. Limper. (2021) Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Nargiz Seyidova, Austin D. Chen, Diana del Valle, David Chi, Ryan P. Cauley, Bernard T. Lee & Samuel J. Lin. (2021) Nationwide cost variation for lower extremity flap reconstruction. European Journal of Plastic Surgery 44:4, pages 475-482.
Crossref
Crossref
Mitra Corral, Eunice Chang, Michael S Broder, Sohum Gokhale & Sheila R Reddy. (2020) Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosis. Journal of Comparative Effectiveness Research 9:13, pages 933-943.
Crossref
Crossref
Lucile Sesé, Warda Khamis, Florence Jeny, Yurdagul Uzunhan, Boris Duchemann, Dominique Valeyre, Isabella Annesi-Maesano & Hilario Nunes. (2020) Adult interstitial lung diseases and their epidemiology. La Presse Médicale 49:2, pages 104023.
Crossref
Crossref
Michael T. Durheim, Jennifer Judy, Shaun Bender, Megan L. Neely, Dorothy Baumer, Scott B. Robinson, Craig S. Conoscenti, Thomas B. Leonard, Howard M. Lazarus & Scott M. Palmer. (2020) A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018. Medicine 99:47, pages e23143.
Crossref
Crossref
Tejaswini Kulkarni & Steven R. Duncan. (2019) Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Who to Treat, How to Treat. Current Pulmonology Reports 8:4, pages 123-130.
Crossref
Crossref
Michael T. Durheim, Jennifer Judy, Shaun Bender, Dorothy Baumer, Joseph Lucas, Scott B. Robinson, Omar Mohamedaly, Bimal R. Shah, Thomas Leonard, Craig S. Conoscenti & Scott M. Palmer. (2019) In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study. Lung 197:6, pages 699-707.
Crossref
Crossref
Xueqing Yu, Xuanlin Li, Liaoyao Wang, Ran Liu, Yang Xie, Suyun Li & Jiansheng Li. (2019) Pulmonary Rehabilitation for Exercise Tolerance and Quality of Life in IPF Patients: A Systematic Review and Meta-Analysis. BioMed Research International 2019, pages 1-9.
Crossref
Crossref
Joseph Cooley, Rick Balestra, Alejandro A. Aragaki-Nakahodo, Danielle N. Caudell Stamper, Thitiwat Sriprasart, Zulma Swank, Robert P. Baughman & Sadia Benzaquen. (2018) Safety of performing transbronchial lung cryobiopsy on hospitalized patients with interstitial lung disease. Respiratory Medicine 140, pages 71-76.
Crossref
Crossref
Alex Diamantopoulos, Emily Wright, Katerina Vlahopoulou, Laura Cornic, Nils Schoof & Toby M. Maher. (2018) The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review. PharmacoEconomics 36:7, pages 779-807.
Crossref
Crossref
Yang Xie, Jia-Jia Wang, Gao-Yang Li, Xuan-Lin Li & Jian-Sheng Li. (2017) Acupuncture for idiopathic pulmonary fibrosis. Medicine 96:52, pages e9114.
Crossref
Crossref
Sabrina Bajwah & Janelle Yorke. (2017) Palliative care and interstitial lung disease. Current Opinion in Supportive & Palliative Care 11:3, pages 141-146.
Crossref
Crossref
Sami M. Aloush. (2017) Does educating nurses with ventilator-associated pneumonia prevention guidelines improve their compliance?. American Journal of Infection Control 45:9, pages 969-973.
Crossref
Crossref
Yet H Khor, Yvonne Ng, Nicole SL Goh, Christine F McDonald & Anne E Holland. (2017) Prognosis of adults with idiopathic pulmonary fibrosis without treatment or without effective therapies. Cochrane Database of Systematic Reviews.
Crossref
Crossref